File Download
  Patent History
  • Application
    PC T/CN2010001705 2010-10-27
  • Publication
    WO 2011050574 2011-05-05
Supplementary

published patent: PHARMACEUTICAL COMPOSITION CONTAINING CYCLOMETALATED N-HETEROCYCLIC CARBENE COMPLEXES FOR CANCER TREATMENT

TitlePHARMACEUTICAL COMPOSITION CONTAINING CYCLOMETALATED N-HETEROCYCLIC CARBENE COMPLEXES FOR CANCER TREATMENT
Priority Date2009-10-28 US 12/255667P
2010-02-05 US 12/301752P
Inventors
Issue Date2011
Citation
WO Published patent application WO 2011050574. World Intellectual Property Organization (WIPO), PatentScope, 2011 How to Cite?
AbstractThe present invention discloses a pharmaceutical composition for treating cancers, comprising a cyclometalated N-heterocyclic carbene complex. Said cyclometalated N-heterocyclic carbene complex contains a gold (III) or platinum (II) atom. The pharmaceutical composition possesses anti-cancer activity such as the induction of cell death, inhibition of cellular proliferation, inhibition of topoisomerase and/or poisoning of topoisomerase.
Persistent Identifierhttp://hdl.handle.net/10722/195812
References

 

DC FieldValueLanguage
dc.date.accessioned2014-03-12T09:15:00Z-
dc.date.available2014-03-12T09:15:00Z-
dc.date.issued2011-
dc.identifier.citationWO Published patent application WO 2011050574. World Intellectual Property Organization (WIPO), PatentScope, 2011en_US
dc.identifier.urihttp://hdl.handle.net/10722/195812-
dc.description.abstractThe present invention discloses a pharmaceutical composition for treating cancers, comprising a cyclometalated N-heterocyclic carbene complex. Said cyclometalated N-heterocyclic carbene complex contains a gold (III) or platinum (II) atom. The pharmaceutical composition possesses anti-cancer activity such as the induction of cell death, inhibition of cellular proliferation, inhibition of topoisomerase and/or poisoning of topoisomerase.en_US
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License for public patent documentsen_US
dc.titlePHARMACEUTICAL COMPOSITION CONTAINING CYCLOMETALATED N-HETEROCYCLIC CARBENE COMPLEXES FOR CANCER TREATMENTen_US
dc.typePatenten_US
dc.identifier.authorityCHE, CHIMING=rp00670en_US
dc.description.naturepublished_or_final_version-
dc.contributor.inventorCHE, CHIMINGen_US
dc.contributor.inventorSUN, WAIYIN, RAYMONDen_US
dc.contributor.inventorCHOW, LOKFUNGen_US
dc.contributor.inventorYAN, JINGen_US
patents.identifier.applicationPC T/CN2010001705en_US
patents.description.assigneeUNIV HONG KONG [CN]; CHE CHIMING [CN]; SUN WAIYIN RAYMOND [CN]; CHOW LOKFUNG [CN]; YAN JING [CN]en_US
patents.description.countryWorld Intellectual Property Organization (WIPO)en_US
patents.date.publication2011-05-05en_US
dc.relation.referencesWO 2009118475 (A2) 2009-10-01en_US
dc.relation.referencesWO 2009118475 (A3) 2009-11-19en_US
dc.relation.referencesCN 101291961 (A) 2008-10-22en_US
dc.relation.referencesCN 101291961 (B) 2011-02-16en_US
dc.relation.referencesWO 2007017047 (A1) 2007-02-15en_US
dc.relation.referencesCN 1926141 (A) 2007-03-07en_US
patents.date.application2010-10-27en_US
patents.date.priority2009-10-28 US 12/255667Pen_US
patents.date.priority2010-02-05 US 12/301752Pen_US
patents.description.ccwoen_US
patents.identifier.publicationWO 2011050574en_US
patents.relation.familyCN 102741262 (A) 2012-10-17en_US
patents.relation.familyEP 2493896 (A1) 2012-09-05en_US
patents.relation.familyUS 2011098264 (A1) 2011-04-28en_US
patents.relation.familyUS 8530659 (B2) 2013-09-10en_US
patents.relation.familyUS 2013324511 (A1) 2013-12-05en_US
patents.description.kindA1en_US
patents.typePatent_publisheden_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats